Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
About this item
Full title
Author / Creator
Chen, Xiangyu , Pan, Zhiwei , Yue, Shuai , Yu, Fei , Zhang, Junsong , Yang, Yang , Li, Ren , Liu, Bingfeng , Yang, Xiaofan , Gao, Leiqiong , Li, Zhirong , Lin, Yao , Huang, Qizhao , Xu, Lifan , Tang, Jianfang , Hu, Li , Zhao, Jing , Liu, Pinghuang , Zhang, Guozhong , Chen, Yaokai , Deng, Kai and Ye, Lilin
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity including severe, moderate, mild, and asymptomatic,...
Alternative Titles
Full title
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7464057
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7464057
Other Identifiers
ISSN
2059-3635,2095-9907
E-ISSN
2059-3635
DOI
10.1038/s41392-020-00301-9
